AbCellera Biologics Inc. Common Shares ABCL
$12.70
+0.40%
at last close
Financials (TTM)
- Revenue
- $66.17 million
- Net Income
- $-164,656,000
- Net Margin
- -248.83%
- Return on Equity
- -18.38%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 4.59
- Price / Sales
- 62.19
Over the trailing twelve months, AbCellera Biologics Inc. Common Shares generated revenue of $66.17 million and net income of $-164,656,000, a net margin of -248.83%.
At the last closing price of $12.70, ABCL trades at 62.19 times sales, with a market capitalization of $4.12 billion.
Key Stats
- Last Close
- $12.70
- Market Cap
- $4.12 billion
- 52-Week Range
- $2.75 – $13.18
- Average Volume
- 5.40 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.